Chest
Selected ReportsMedical Pneumonectomy: Interventional Bronchoscopic and Endovascular Management of Massive Hemoptysis Due to Pulmonary Artery Pseudoaneurysm, a Consequence of Endobronchial Brachytherapy
Section snippets
Discussion
Endobronchial brachytherapy serves well in treating residual or recurrent carcinoma. It can be effective for patients who have been treated with maximal doses of external beam radiation. However, it can be potentially dangerous. Massive hemoptysis and mediastinal fistulae are the most common complications.1
Traumatic, infectious, rheumatologic, and malignant causes of pulmonary artery pseudoaneurysm have been well documented in the literature. It is an uncommon yet well-known iatrogenic
Conclusions
Massive hemoptysis is a significant risk of endobronchial brachytherapy. Pulmonary artery pseudoaneurysm can result at a delayed time from initial therapy. This entity can be successfully managed through bronchoscopic and endovascular techniques.
References (5)
- et al.
Endobronchial brachytherapy
Clin Chest Med
(1995) - et al.
Endovascular stent-graft repair of a pulmonary artery-bronchial fistula
J Vasc Interv Radiol
(2003)
Cited by (0)
No conflict of interest exists for any of the authors.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/site/misc/reprints.xhtml).